Overview

Geron Corporation is a biotechnology company focused on the development and commercialization of innovative drugs for cancer treatment. The company is a leader in telomerase inhibitors, with its lead drug, imetelstat, undergoing various stages of clinical trials for hematologic malignancies.

Therapeutic areas

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Geron Corporation in our records. PharmaTek screens the full directory against live FDA enforcement data.

Verified Supplier Partner

Is this Geron Corporation? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.